1
|
Brynzak-Schreiber E, Schögl E, Bapp C, Cseh K, Kopatz V, Jakupec MA, Weber A, Lange T, Toca-Herrera JL, Del Favero G, Wadsak W, Kenner L, Pichler V. Microplastics role in cell migration and distribution during cancer cell division. Chemosphere 2024; 353:141463. [PMID: 38423146 DOI: 10.1016/j.chemosphere.2024.141463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 02/08/2024] [Accepted: 02/13/2024] [Indexed: 03/02/2024]
Abstract
Amidst the global plastic pollution crisis, the gastrointestinal tract serves as the primary entry point for daily exposure to micro- and nanoplastics. We investigated the complex dynamics between polystyrene micro- and nanoplastics (PS-MNPs) and four distinct human colorectal cancer cell lines (HT29, HCT116, SW480, and SW620). Our findings revealed a significant size- and concentration dependent uptake of 0.25, 1, and 10 μm PS-MNPs across all cell lines, with HCT116 cells exhibiting the highest uptake rates. During cell division, particles were distributed between mother and daughter cells. Interestingly, we observed no signs of elimination from the cells. Short-term exposure to 0.25 μm particles significantly amplified cell migration, potentially leading to pro-metastatic effects. Particles demonstrated high persistence in 2D and 3D cultures, and accumulation in non-proliferating parts of spheroids, without interfering with cell proliferation or division. Our study unveils the disturbing fact of the persistence and bioaccumulation of MNPs in colorectal cancer cell lines, key toxicological traits under REACH (Regulation concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals). Our observations underscore the potential of MNPs as hidden catalysts for tumor progression, particularly through enhancing cell migration and possibly fueling metastasis - a finding that sheds light on a significant and previously underexplored area of concern.
Collapse
Affiliation(s)
- Ekaterina Brynzak-Schreiber
- University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Vienna, Austria
| | - Elisabeth Schögl
- University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Vienna, Austria; University of Natural Resources and Life Sciences Vienna (BOKU), Department of Bionanosciences, Institute of Biophysics, Vienna, Austria
| | - Carolin Bapp
- University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Vienna, Austria
| | - Klaudia Cseh
- University of Vienna, Faculty of Chemistry, Institute of Inorganic Chemistry, Vienna, Austria
| | - Verena Kopatz
- Medical University of Vienna, Clinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Vienna, Austria; CBmed GmbH - Center for Biomarker Research in Medicine, Graz, Styria, Austria; Department for Radiation Oncology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria
| | - Michael A Jakupec
- University of Vienna, Faculty of Chemistry, Institute of Inorganic Chemistry, Vienna, Austria
| | - Andreas Weber
- University of Natural Resources and Life Sciences Vienna (BOKU), Department of Bionanosciences, Institute of Biophysics, Vienna, Austria
| | - Tobias Lange
- Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Anatomy I, Jena University Hospital, Jena, Germany; Comprehensive Cancer Center Central Germany (CCCG), Germany
| | - José L Toca-Herrera
- University of Natural Resources and Life Sciences Vienna (BOKU), Department of Bionanosciences, Institute of Biophysics, Vienna, Austria
| | - Giorgia Del Favero
- University of Vienna, Faculty of Chemistry, Department of Food Chemistry and Toxicology, Vienna, Austria; University of Vienna, Faculty of Chemistry, Core Facility Multimodal Imaging, Vienna, Austria
| | - Wolfgang Wadsak
- CBmed GmbH - Center for Biomarker Research in Medicine, Graz, Styria, Austria; Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Vienna, Austria
| | - Lukas Kenner
- Medical University of Vienna, Clinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Vienna, Austria; CBmed GmbH - Center for Biomarker Research in Medicine, Graz, Styria, Austria; Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria; Christian Doppler Laboratory for Applied Metabolomics, Medical University Vienna, Vienna, Austria.
| | - Verena Pichler
- University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Vienna, Austria; CBmed GmbH - Center for Biomarker Research in Medicine, Graz, Styria, Austria.
| |
Collapse
|